Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Costimulation improves the killing capability of T cells redirected to tumor cells expressing low levels of CD33: description of a novel modular targeting system.
Arndt C, Feldmann A, von Bonin M, Cartellieri M, Ewen EM, Koristka S, Michalk I, Stamova S, Berndt N, Gocht A, Bornhäuser M, Ehninger G, Schmitz M, Bachmann M. Arndt C, et al. Among authors: stamova s. Leukemia. 2014 Jan;28(1):59-69. doi: 10.1038/leu.2013.243. Epub 2013 Aug 20. Leukemia. 2014. PMID: 23958923
Retargeting of human regulatory T cells by single-chain bispecific antibodies.
Koristka S, Cartellieri M, Theil A, Feldmann A, Arndt C, Stamova S, Michalk I, Töpfer K, Temme A, Kretschmer K, Bornhäuser M, Ehninger G, Schmitz M, Bachmann M. Koristka S, et al. Among authors: stamova s. J Immunol. 2012 Feb 1;188(3):1551-8. doi: 10.4049/jimmunol.1101760. Epub 2011 Dec 19. J Immunol. 2012. PMID: 22184723
Novel humanized and highly efficient bispecific antibodies mediate killing of prostate stem cell antigen-expressing tumor cells by CD8+ and CD4+ T cells.
Feldmann A, Arndt C, Töpfer K, Stamova S, Krone F, Cartellieri M, Koristka S, Michalk I, Lindemann D, Schmitz M, Temme A, Bornhäuser M, Ehninger G, Bachmann M. Feldmann A, et al. Among authors: stamova s. J Immunol. 2012 Sep 15;189(6):3249-59. doi: 10.4049/jimmunol.1200341. Epub 2012 Aug 8. J Immunol. 2012. PMID: 22875801
Retargeting of regulatory T cells to surface-inducible autoantigen La/SS-B.
Koristka S, Cartellieri M, Arndt C, Bippes CC, Feldmann A, Michalk I, Wiefel K, Stamova S, Schmitz M, Ehninger G, Bornhäuser M, Bachmann M. Koristka S, et al. Among authors: stamova s. J Autoimmun. 2013 May;42:105-16. doi: 10.1016/j.jaut.2013.01.002. Epub 2013 Jan 22. J Autoimmun. 2013. PMID: 23352111
Redirection of T cells with a first fully humanized bispecific CD33-CD3 antibody efficiently eliminates AML blasts without harming hematopoietic stem cells.
Arndt C, von Bonin M, Cartellieri M, Feldmann A, Koristka S, Michalk I, Stamova S, Bornhäuser M, Schmitz M, Ehninger G, Bachmann M. Arndt C, et al. Among authors: stamova s. Leukemia. 2013 Apr;27(4):964-7. doi: 10.1038/leu.2013.18. Epub 2013 Jan 17. Leukemia. 2013. PMID: 23325142 No abstract available.
Chimeric antigen receptor-engineered T cells for immunotherapy of cancer.
Cartellieri M, Bachmann M, Feldmann A, Bippes C, Stamova S, Wehner R, Temme A, Schmitz M. Cartellieri M, et al. Among authors: stamova s. J Biomed Biotechnol. 2010;2010:956304. doi: 10.1155/2010/956304. Epub 2010 May 5. J Biomed Biotechnol. 2010. PMID: 20467460 Free PMC article. Review.
29 results